Telomir Pharmaceuticals(TELO) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

TELO Telomir Pharmaceuticals

Watchlist

4.390
-0.140-3.09%

Trading Mar 25 12:55 ET

130.66MMarket Cap-7.91P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Telomir Pharmaceuticals Announces Preclinical Findings on Telomir-1
TipRanksMar 19 08:21 ET
Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells
AccesswireMar 19 08:00 ET
Express News | Telomir Pharmaceuticals Says 'Telomir-1 Alone at Both Low and High Doses Reduced Tumor Growth by Approximately 50%'
BenzingaMar 19 07:39 ET
Express News | Telomir Pharmaceuticals Says 'Telomir-1 Inhibits Tumor Growth, Suppresses Cancer Progression, and Neutralizes Chemotherapy Toxicity'
BenzingaMar 19 07:39 ET
Telomir Pharmaceuticals Lead Drug Candidate Inhibits Tumor Growth In Aggressive Prostate Cancer Cells, Animal Study Shows
BenzingaMar 19 07:37 ET
Express News | Telomir Pharmaceuticals - Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model
ReutersMar 19 07:32 ET

Comments

Jaguar8

Mar 20 05:42

⚫️Watchlist, MARCH 20,2025, Thursday. NFA -DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If...

Teddy123

Mar 19 21:14

Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells

$Telomir Pharmaceuticals (TELO.US)$
Breakthrough: New Cancer Drug Cuts Prostate Tumors by Half While Reducing Chemo Toxicity

Trytosaveabit

Mar 19 19:42

Update

$Telomir Pharmaceuticals (TELO.US)$ Telomir Pharmaceuticals Lead Drug Candidate Inhibits Tumor Growth In Aggressive Prostate Cancer Cells, Animal Study Shows
Benzinga· 4 mins ago
On Wednesday, Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) revealed preclinical findings demonstrating that Telomir-1 reduces tumor size by approximately 50% in a prostate cancer animal model with aggressive cancer cells.
The company says that Telomir-1 actively suppresses cancer growth and protects against chemothe...